Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Boston University |
---|---|
Information provided by: | Boston University |
ClinicalTrials.gov Identifier: | NCT00406692 |
In this study the influence of zonisamide administration over a 13 week period on alcohol consumption in alcoholic (alcohol dependent) subjects will be examined. The dose of zonisamide given to subjects will be slowly increased over a period of several weeks. They will receive a full dose over a 5 week period. This will be a pilot study in which all of the subjects will only receive zonisamide. A primary objective of this study is to determine the possible size of the effect that zonisamide administration has on drinking (i.e. drinks consumed per day) to allow us to plan for a larger clinical trial of the effects of zonisamide on alcohol dependence.
Condition | Intervention | Phase |
---|---|---|
Alcoholism |
Drug: Zonisamide |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | The Effects of Zonisamide on Alcohol Dependence |
Estimated Enrollment: | 20 |
Study Start Date: | November 2006 |
Estimated Study Completion Date: | November 2010 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 21 Years to 64 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
INCLUSION CRITERIA
To be admitted into this study patients must meet the following criteria:
EXCLUSION CRITERIA
Patients meeting the following criteria will be excluded from the study:
United States, Massachusetts | |
Boston University School of Medicine | |
Boston, Massachusetts, United States, 02118 |
Principal Investigator: | Clifford Knapp, PhD | Boston University |
Responsible Party: | Boston University ( Clifford Knapp, PhD ) |
Study ID Numbers: | H-25544 |
Study First Received: | November 30, 2006 |
Last Updated: | August 8, 2008 |
ClinicalTrials.gov Identifier: | NCT00406692 |
Health Authority: | United States: Institutional Review Board |
Zonisamide Alcoholism Alcohol |
Mental Disorders Zonisamide Alcoholism Substance-Related Disorders |
Disorders of Environmental Origin Alcohol-Related Disorders Ethanol |
Antioxidants Molecular Mechanisms of Pharmacological Action Therapeutic Uses Physiological Effects of Drugs |
Central Nervous System Agents Protective Agents Anticonvulsants Pharmacologic Actions |